Overview

A Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With 2 Formulations (Panadol and SafeTynadol) in Healthy Volunteers

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To investigate and compare the possible response of Panadol® and SafeTynadol® formulations in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Sinew Pharma Inc.
Treatments:
Acetaminophen